Charalambos Andreadis

14.9k citations
127 papers · 3.3k indexed · 1 hit paper · h-index 27
Topics
Lymphoma Diagnosis and Treatment (48 papers)CAR-T cell therapy research (35 papers)Chronic Lymphocytic Leukemia Research (18 papers)

In The Last Decade

Charalambos Andreadis

122 papers receiving 3.3k citations

Hit Papers

ATP citrate lyase inhibition can suppress tumor cell growth20052026201220192005250500750

Peers

Charalambos Andreadis
Comparison fields: 5 of 113
  • Molecular Biology 1.5k
  • Oncology 1.4k
  • Cancer Research 1.0k
  • Pathology and Forensic Medicine 650
  • Immunology 300
Replace Gerald W. Prager with:
Gerald W. Prager Austria
Ellis Levine United States
Yoshio Naomoto Japan
Yasushi Ichikawa Japan
Shunsuke Kato Japan
Aiwu Ruth He United States
Walter E. Aulitzky Germany
Arndt Hartmann Germany
Nevins W. Todd United States
Joanna H. Tong Hong Kong
Charalambos Andreadis relative to Gerald W. Prager Austria Gerald W. Prager's profile →
Citations per field
00.5×1.6×
Gerald W. Prager · 1×
Citations per year

Countries citing papers authored by Charalambos Andreadis

Since Specialization
Citations

This map shows the geographic impact of Charalambos Andreadis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalambos Andreadis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalambos Andreadis more than expected).

Fields of papers citing papers by Charalambos Andreadis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalambos Andreadis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalambos Andreadis. The network helps show where Charalambos Andreadis may publish in the future.

Co-authorship network of co-authors of Charalambos Andreadis

This figure shows the co-authorship network connecting the top 25 collaborators of Charalambos Andreadis. A scholar is included among the top collaborators of Charalambos Andreadis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalambos Andreadis. Charalambos Andreadis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 10
5 7
6 4
7 33
8 16
9 89
10 16
11 2
12 5
13 4
14 10
15 2
16 2
17 6
18 29
19 9
20 52

About Charalambos Andreadis

Charalambos Andreadis is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology, having authored 127 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (48 papers), CAR-T cell therapy research (35 papers) and Chronic Lymphocytic Leukemia Research (18 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Pathology and Forensic Medicine (650 citations). Charalambos Andreadis has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Craig B. Thompson, Georgia Hatzivassiliou, Fangping Zhao, Daniel E. Bauer, Dashyant Dhanak, Anthony N. Shaw, Sunil R. Hingorani, David A. Tuveson, Stephen J. Schuster and Jeremy S. Abramson. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026